Loading provider…
Loading provider…
Cardiovascular Disease Physician in West Hills, CA
NPI: 1740433705Primary Practice Location
Interventional Cardiology Medical Group, Inc
23101 W Sherman Pl, West Hills, CA
Primary Employer
Interventional Cardiology Medical Group, Inc
icardiomg.com
HQ Phone
Get M.D. Farhad's Phone Numberphone_androidMobile
Get M.D. Farhad's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2008 - 2026
TX State Medical License
2014 - 2014

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Cardiovascular Disease

Certification Board of Nuclear Cardiology
Board Certified, Nuclear Cardiology

International Board of Heart Rhythm Examiners
Certified Cardiac Device Specialist

National Board of Echocardiography
Certified Adult Comprehensive Echocardiography
David Geffen School of Medicine at UCLA
medschool.ucla.edu
BS • Biology
2001 - 2003
Keck School of Medicine of USC
keck.usc.edu
Medical School
Until 2007
University of California (San Francisco)/Fresno
Fellowship • Cardiovascular Disease
2010 - 2013
Kaiser Permanente Southern California (Los Angeles)
Residency • Internal Medicine
2007 - 2010
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 643 | 1,294 |
| 2 | 93306Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | 384 | 403 |
| 3 | 93000Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 377 | 466 |
| 4 | 99457Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 318 | 2,535 |
| 5 | 99454Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 290 | 2,082 |
Authors: Naqvi, Tasneem Z, Padmanabhan, Sriram, Rafii, Farhad, Hyuhn, Hahn K, Mirocha, James
Journal: Am J Cardiol
Publication Date: 2005-11-17
Lead Sponsor: Novartis Pharmaceuticals
Intervention / Treatment: DRUG: Placebo, DRUG: TQJ230
Lead Sponsor: American Regent, Inc.
Collaborators: Duke Clinical Research Institute
Intervention / Treatment: DRUG: Placebo, DRUG: Ferric Carboxymaltose